Cargando…
LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
Long non-coding RNA NBR2 is a transcript of the neighbor of BRCA1 gene 2 and can regulate tumor development. However, there is little information on the role of NBR2 in the progression of thyroid cancers (TC). Here, we show that NBR2 expression is down-regulated in TC tissues and associated with his...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304297/ https://www.ncbi.nlm.nih.gov/pubmed/32596161 http://dx.doi.org/10.3389/fonc.2020.00956 |
_version_ | 1783548237382156288 |
---|---|
author | Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui |
author_facet | Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui |
author_sort | Yang, Wen |
collection | PubMed |
description | Long non-coding RNA NBR2 is a transcript of the neighbor of BRCA1 gene 2 and can regulate tumor development. However, there is little information on the role of NBR2 in the progression of thyroid cancers (TC). Here, we show that NBR2 expression is down-regulated in TC tissues and associated with histologic subtypes of TC. NBR2 expression was variably reduced in different TC cells. While NBR2 silencing significantly enhanced the malignancy of BCPAP cells by increasing cell proliferation, clonogenicity, wound healing, and invasion as well as tumor growth in vivo, and decreasing spontaneous apoptosis, NBR2 over-expression had opposite effects in BHT101 cells. Furthermore, treatment with A-769662 (a specific AMPK activator), like NBR2 over-expression, significantly attenuated the malignancy of BHT101 cells while treatment with Compound C (a specific AMPK inhibitor) significantly rescued that NBR2-reduced malignancy of BHT101 cells. In comparison with non-tumor thyroid epithelial Nthy-ori 3-1 cells, obviously increased GLUT-1 expression, but decreased AMPK and ACC phosphorylation were detected in TC cells. While NBR2 silencing further enhanced GLUT-1 expression and reduced AMPK and ACC phosphorylation as well as the EMT process in BCPAP cells. NBR2 over-expression also had opposite effects in BHT101 cells. Similar patterns of GLUT-1 expression and AMPK and ACC phosphorylation were detected in the different types of xenograft TC tumors in vivo. Therefore, such data indicated that NBR2 acted as a tumor suppressor of thyroid cancers associated with enhancing the AMPK signaling and NBR2 may be a potential biomarker and therapeutic target for thyroid cancers. |
format | Online Article Text |
id | pubmed-7304297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73042972020-06-26 LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui Front Oncol Oncology Long non-coding RNA NBR2 is a transcript of the neighbor of BRCA1 gene 2 and can regulate tumor development. However, there is little information on the role of NBR2 in the progression of thyroid cancers (TC). Here, we show that NBR2 expression is down-regulated in TC tissues and associated with histologic subtypes of TC. NBR2 expression was variably reduced in different TC cells. While NBR2 silencing significantly enhanced the malignancy of BCPAP cells by increasing cell proliferation, clonogenicity, wound healing, and invasion as well as tumor growth in vivo, and decreasing spontaneous apoptosis, NBR2 over-expression had opposite effects in BHT101 cells. Furthermore, treatment with A-769662 (a specific AMPK activator), like NBR2 over-expression, significantly attenuated the malignancy of BHT101 cells while treatment with Compound C (a specific AMPK inhibitor) significantly rescued that NBR2-reduced malignancy of BHT101 cells. In comparison with non-tumor thyroid epithelial Nthy-ori 3-1 cells, obviously increased GLUT-1 expression, but decreased AMPK and ACC phosphorylation were detected in TC cells. While NBR2 silencing further enhanced GLUT-1 expression and reduced AMPK and ACC phosphorylation as well as the EMT process in BCPAP cells. NBR2 over-expression also had opposite effects in BHT101 cells. Similar patterns of GLUT-1 expression and AMPK and ACC phosphorylation were detected in the different types of xenograft TC tumors in vivo. Therefore, such data indicated that NBR2 acted as a tumor suppressor of thyroid cancers associated with enhancing the AMPK signaling and NBR2 may be a potential biomarker and therapeutic target for thyroid cancers. Frontiers Media S.A. 2020-06-12 /pmc/articles/PMC7304297/ /pubmed/32596161 http://dx.doi.org/10.3389/fonc.2020.00956 Text en Copyright © 2020 Yang, Zheng, Yi, Wang, Zhang, Ming, Tan and Guo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title | LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_full | LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_fullStr | LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_full_unstemmed | LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_short | LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_sort | lncrna nbr2 inhibits the malignancy of thyroid cancer, associated with enhancing the ampk signaling |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304297/ https://www.ncbi.nlm.nih.gov/pubmed/32596161 http://dx.doi.org/10.3389/fonc.2020.00956 |
work_keys_str_mv | AT yangwen lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT zhengzhikun lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT yipengfei lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT wangshi lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT zhangning lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT mingjie lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT tanjie lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT guohui lncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling |